Drug helps maintain platelet inhibition and anti-clotting levels prior to cardiac surgery
Patients who discontinued use of an antiplatelet agent such as clopidogrel prior to undergoing cardiac surgery to lower their bleeding risk and received intravenously the platelet inhibitor cangrelor achieved a higher rate ...
Jan 17, 2012
0
0